TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10219129

Group type: EXPERIMENTAL
Intervention: Brånemark, IMZ or Frialit‐2 endosseous implants with autogenous bone grafts
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral implants in periodontally healthy patients
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IMZ, Brånemark and Frialit‐2 abutments
Number of subjects: 50
Study: 7597209

Group type: EXPERIMENTAL
Intervention: Iridium-192 boost (20 Gy)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Cobalt-60 boost (20 Gy)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 255
Study: 2362111

Group type: EXPERIMENTAL
Intervention: Resuscitation bag controller (RC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual resuscitation bags (MRB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both methods (RC and MRB)
Number of subjects: 25
Study: 469022

Group type: EXPERIMENTAL
Intervention: Quinidine sulfate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Quinidine gluconate
Number of subjects: 20
Study: 11311100

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 1342

Group type: COMPARATOR
Intervention: Normal glucose levels
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Isolated IFG
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Isolated IGT
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Both IFG and IGT
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Waist-hip ratio
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose (FPG)
Number of subjects: 1342

Group type: EXPERIMENTAL
Intervention: 2-hour postload glucose levels
Number of subjects: 1342
Study: 31387158

Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) during exercise
Number of subjects: 19
Study: 30120812

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 27412814

Group type: EXPERIMENTAL
Intervention: PNA FISH
Number of subjects: 220
Study: 25456960

Group type: EXPERIMENTAL
Intervention: Acupuncture (Electroacupuncture)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Acupuncture (Traditional Acupuncture)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (Standard postoperative analgesic treatment with acetaminophen)
Number of subjects: 121
Study: 23364039

Group type: EXPERIMENTAL
Intervention: Recreational combination gymnastics program (conducted twice a week for 12 weeks)
Number of subjects: 53
Study: 20425851

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI), 5 ml nebulized treatment twice a day for 28 days (one cycle), followed by 28 days off, for three cycles.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 32
Study: 17681169

Group type: EXPERIMENTAL
Intervention: Hepatic venous pressure gradient (HVPG)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Model of end-stage liver disease (MELD)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 213
Study: 15739091

Group type: EXPERIMENTAL
Intervention: Local anesthetics (group 2, n=17)
Number of subjects: 35

Group type: COMPARATOR
Intervention: 5 ml saline (group 1, n=18)
Number of subjects: 35
Study: 12090575

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 7161

Group type: COMPARATOR
Intervention: Open non-mesh repair
Number of subjects: 7161

Group type: COMPARATOR
Intervention: Open mesh methods
Number of subjects: 7161
Study: 9682119

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% (1.5 micrograms)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (BSS)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Both groups (Latanoprost and Control)
Number of subjects: 103
Study: 8590488

Group type: EXPERIMENTAL
Intervention: Ketamine (2 mg.kg‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg.kg‐1)
Number of subjects: 30
Study: 1967418

Group type: EXPERIMENTAL
Intervention: Low-dose bradykinin infusion (30 ng/kg per min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Chronic bradykinin administration (6 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 279137

Group type: EXPERIMENTAL
Intervention: 0.5% sodium fluoride solution (weekly mouth-rinsings)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 58
Study: 31931509

Group type: EXPERIMENTAL
Intervention: Nicotine (2-mg lozenge)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31284833

Group type: EXPERIMENTAL
Intervention: 2D illustrations
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 3D-printed models
Number of subjects: 41

Group type: COMPARATOR
Intervention: Overall educational outcome
Number of subjects: 41
Study: 29042392

Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 25889057

Group type: EXPERIMENTAL
Intervention: Cognitive tests administered in a familiar environment (Familiar cohort)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cognitive tests administered in a foreign environment (Foreign cohort)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caregiver reports for both cohorts
Number of subjects: 9
Study: 23427930

Group type: EXPERIMENTAL
Intervention: Pelvic girdle pain (PGP)
Number of subjects: 27
Study: 22007904

Group type: EXPERIMENTAL
Intervention: Adapalene gel and nadifloxacin cream
Number of subjects: 50

Group type: COMPARATOR
Intervention: Adapalene gel monotherapy
Number of subjects: 50
Study: 19797187

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg/d)
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1360
Study: 16825271

Group type: EXPERIMENTAL
Intervention: Oral magnesium 15 mmol twice daily (n = 28)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 53
Study: 12868253

Group type: EXPERIMENTAL
Intervention: Fennel seed oil emulsion
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 9862830

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (0, 0.375, 0.75, and 1.5 pmol/kg/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (highest dose)
Number of subjects: 16
Study: 8549029

Group type: EXPERIMENTAL
Intervention: Atovaquone (750 mg every 12 hours)
Number of subjects: 14
Study: 1834003

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 7

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 7

Group type: COMPARATOR
Intervention: Warfarin and Aspirin
Number of subjects: 7
Study: 6800440

Group type: EXPERIMENTAL
Intervention: Preseasonal hyposensitisation treatment with an aqueous rye extract
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 20
Study: 31424665

Group type: EXPERIMENTAL
Intervention: Endoscopic mucosal resection (EMR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 28004259

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (psycho-education, motivational interviewing, and short message services)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 288
Study: 26697176

Group type: EXPERIMENTAL
Intervention: Ranolazine (500 mg, uptitrated to 1,000 mg at week 4)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 23452432

Group type: EXPERIMENTAL
Intervention: Prediction model for OTC-medication use based on maternal characteristics
Number of subjects: 1246
Study: 21488067

Group type: EXPERIMENTAL
Intervention: Filibuvir 100 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filibuvir 700 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filibuvir 450 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filibuvir (various doses)
Number of subjects: 0
Study: 19479489

Group type: EXPERIMENTAL
Intervention: Estradiol 0.014 mg/day
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 16537662

Group type: EXPERIMENTAL
Intervention: Candesartan (Atacand, AstraZeneca) for two years
Number of subjects: 772

Group type: COMPARATOR
Intervention: Placebo for two years
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Candesartan (Atacand, AstraZeneca) for four years
Number of subjects: 772

Group type: COMPARATOR
Intervention: Placebo for four years
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Candesartan (Atacand, AstraZeneca)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 772
Study: 12741670

Group type: EXPERIMENTAL
Intervention: Manipulated cognitive sets of raters (dimensional vs categorical)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rating scale measures
Number of subjects: 0
Study: 11112084

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 70
Study: 9759389

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.02 mg/ml, three times daily for 5 days)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thio-tepa (four times daily for 6 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Distilled water (three times daily for 5 days)
Number of subjects: 36
Study: 7812727

Group type: EXPERIMENTAL
Intervention: Na-PMP (2(‐4‐methoxyphenoxy)propanoic acid sodium salt)
Number of subjects: 0
Study: 2900187

Group type: EXPERIMENTAL
Intervention: Somatostatin (SRIF) 4 micrograms/kg injected before cannulation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 29747618

Group type: EXPERIMENTAL
Intervention: Multimodal school-based stepped-prevention program for depression and suicidal behaviors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening and safety net of gatekeepers at schools (Control)
Number of subjects: 0
Study: 28061767

Group type: EXPERIMENTAL
Intervention: Prostaglandin
Number of subjects: 368

Group type: COMPARATOR
Intervention: No prostaglandin (amniotomy and/or oxytocin)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Prostaglandin and No prostaglandin
Number of subjects: 368
Study: 26171392

Group type: EXPERIMENTAL
Intervention: Intra-articular bupivacaine combined with intravenous parecoxib
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intravenous parecoxib monotherapy (control group)
Number of subjects: 36
Study: 23919274

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg twice daily) and UDCA (1000-2000 mg daily, 20-30 mg/kg/day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Celecoxib and placebo
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison between celecoxib/UDCA and celecoxib/placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Celecoxib and UDCA
Number of subjects: 37
Study: 21179434

Group type: EXPERIMENTAL
Intervention: Mass azithromycin treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: No antibiotic treatment (Control)
Number of subjects: 12
Study: 18375998

Group type: COMPARATOR
Intervention: Abciximab infusion
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: High-dose bolus tirofiban
Number of subjects: 745

Group type: COMPARATOR
Intervention: Uncoated stents
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 745
Study: 16801929

Group type: EXPERIMENTAL
Intervention: Contingent reinforcement for each fruit and vegetable serving consumed during lunch
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-contingent reinforcement irrespective of food intake
Number of subjects: 6
Study: 12113544

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM), 2.0 mg/kg/hr, administered intravenously starting 24 hours before surgery until postoperative day 3 (preop GM group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM), administered at the beginning of surgery (intraop GM group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (without GM)
Number of subjects: 66
Study: 10458715

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing (pacing-on)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Pacing-off
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dobutamine stimulation after 1 year
Number of subjects: 9
Study: 7796558

Group type: EXPERIMENTAL
Intervention: Glucomannan with a 1.200 kcal diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo with a 1.200 kcal diet
Number of subjects: 30
Study: 2368745

Group type: EXPERIMENTAL
Intervention: Drug-use review (DUR) program intervention
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group (no mailing)
Number of subjects: 288
Study: 627704

Group type: EXPERIMENTAL
Intervention: Sodium fluoride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inorganic phosphate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxymetholone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6196006

Group type: EXPERIMENTAL
Intervention: ancrod (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: low‐molecular weight dextran and mannitol (group A)
Number of subjects: 30
Study: 31591708

Group type: EXPERIMENTAL
Intervention: PRIME designated studies
Number of subjects: 138

Group type: COMPARATOR
Intervention: Non-PRIME designated products
Number of subjects: 138
Study: 29653652

Group type: EXPERIMENTAL
Intervention: Betrixaban for 35-42 days
Number of subjects: 7513

Group type: EXPERIMENTAL
Intervention: Betrixaban (80 mg)
Number of subjects: 7513

Group type: COMPARATOR
Intervention: Enoxaparin for 6-14 days
Number of subjects: 7513
Study: 26271300

Group type: EXPERIMENTAL
Intervention: Coder reviewed results of a recent ecological assessment
Number of subjects: 46

Group type: COMPARATOR
Intervention: No ecological assessment information provided to coder
Number of subjects: 46
Study: 23417666

Group type: EXPERIMENTAL
Intervention: Fast Track multi‐component preventive intervention
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1199
Study: 22464802

Group type: COMPARATOR
Intervention: Control diet + supplement
Number of subjects: 8
Study: 19417194

Group type: EXPERIMENTAL
Intervention: Housing and case management program
Number of subjects: 407

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 407
Study: 17901014

Group type: EXPERIMENTAL
Intervention: Occupation-focused, client-centered occupational therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 16
Study: 16301247

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11879528

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10668106

Group type: EXPERIMENTAL
Intervention: Fixed repetition rate and 30 Hz low pass filter
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Randomly varied stimulus repetition rate and 100 Hz low pass filter
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 1 h retest
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2-h retest
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 24-h retest
Number of subjects: 22
Study: 8652236

Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 2087329

Group type: EXPERIMENTAL
Intervention: Needle acupuncture (stainless steel needles at point Hegu (L.I.4) on both sides)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Laser acupuncture (helium-neon laser at points Hegu (L.I.4) and Jianqian (Extra.) on both sides for 1 min)
Number of subjects: 79
Study: 390674

Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid, 200 mg three times a day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Ibuprofen, 400 mg three times a day
Number of subjects: 41
Study: 31965072

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle counseling (dietary intervention and exercise training)
Number of subjects: 40
Study: 31568698

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) supplementation (20 g/d) for 3 months
Number of subjects: 166
Study: 29912918

Group type: EXPERIMENTAL
Intervention: Girls-only intervention group
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Mixed-gender intervention group
Number of subjects: 259

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 259
Study: 26865516

Group type: EXPERIMENTAL
Intervention: Highly malignant EEG (suppression, suppression with periodic discharges, burst‐suppression)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Any malignant EEG feature
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Two malignant EEG features
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Benign EEG
Number of subjects: 202
Study: 24389453

Group type: EXPERIMENTAL
Intervention: Sacha inchi oil (10 or 15ml daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sunflower oil (10 or 15ml daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sacha inchi oil and Sunflower oil
Number of subjects: 30
Study: 22968159

Group type: EXPERIMENTAL
Intervention: Nebulized hypertonic saline containing hyaluronic acid (Hyaneb)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nebulized hypertonic saline solution alone
Number of subjects: 0
Study: 19560158

Group type: EXPERIMENTAL
Intervention: Thimerosal-containing vaccines
Number of subjects: 72
Study: 17439382

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 15850499

Group type: EXPERIMENTAL
Intervention: Isradipine (30 mg SR at bedtime, plus 15 mg IR administered 2 h before methamphetamine infusion)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 18
Study: 12638320

Group type: EXPERIMENTAL
Intervention: Wave intensity (WI) measurement in DCM patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Wave intensity (WI) measurement in heart transplant patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Wave intensity (WI) measurement in healthy volunteers
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cardiac output measurement in DCM patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cardiac output measurement in heart transplant patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Diastolic heart function assessment in DCM patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Diastolic heart function assessment in heart transplant patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Diastolic heart function assessment in healthy individuals
Number of subjects: 31
Study: 9987143

Group type: EXPERIMENTAL
Intervention: Vi capsular polysaccharide vaccine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Meningococcal A + C control vaccine
Number of subjects: 83
Study: 8657431

Group type: EXPERIMENTAL
Intervention: +tramadol
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: tramadol racemate
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: -tramadol
Number of subjects: 98
Study: 1692602

Group type: EXPERIMENTAL
Intervention: Intranasal interferon
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 127
Study: 487092

Group type: EXPERIMENTAL
Intervention: Ankle displacement with subject instructed to relax
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ankle displacement with subject opposing sudden displacement
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visual stimulus response latency
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Torque response to ankle displacement
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Magnitude of displacement velocity
Number of subjects: 18
Study: 30924903

Group type: EXPERIMENTAL
Intervention: Indications-based computerized provider order entry prototype
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vendor 1's electronic prescribing system
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vendor 2's electronic prescribing system
Number of subjects: 32
Study: 29030343

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet with 15-min postmeal walks (LC + Ex)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-fat control diet (CON)
Number of subjects: 11
Study: 26856491

Group type: EXPERIMENTAL
Intervention: Parent education Through Simulation‐Diabetes (PETS‐D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison data results
Number of subjects: 0
Study: 23834667

Group type: EXPERIMENTAL
Intervention: Cognitive bibliotherapy (4-week program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed-treatment control group
Number of subjects: 0
Study: 23107250

Group type: EXPERIMENTAL
Intervention: Outside-in (OI) technique
Number of subjects: 39

Group type: COMPARATOR
Intervention: Transportal (TP) technique
Number of subjects: 39
Study: 19535229

Group type: EXPERIMENTAL
Intervention: Sublingual orally disintegrating olanzapine (ODO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard olanzapine tablets (SOT)
Number of subjects: 0
Study: 17280773

Group type: EXPERIMENTAL
Intervention: Desmopressin (0.1, 0.2, or 0.4 mg)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 15088136

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (Z)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Home infusions
Number of subjects: 184
Study: 11427834

Group type: EXPERIMENTAL
Intervention: Propofol PCS (0.3 mg/kg bolus, zero lockout)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intravenous midazolam (0.05 mg/kg bolus, 1 mg increments as required)
Number of subjects: 88